Meeder Asset Management’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-3,578
| Closed | -$27K | – | 2501 |
|
|
2021
Q3 | $27K | Buy |
3,578
+371
| +12% | +$2.8K | ﹤0.01% | 1322 |
|
|
2021
Q2 | $22K | Sell |
3,207
-366
| -10% | -$2.51K | ﹤0.01% | 1436 |
|
|
2021
Q1 | $37K | Buy |
+3,573
| New | +$37K | ﹤0.01% | 1201 |
|
|
2020
Q4 | – | Sell |
-3,451
| Closed | -$29K | – | 2338 |
|
|
2020
Q3 | $29K | Sell |
3,451
-582
| -14% | -$4.89K | ﹤0.01% | 1073 |
|
|
2020
Q2 | $28K | Buy |
4,033
+3,077
| +322% | +$21.4K | ﹤0.01% | 1058 |
|
|
2020
Q1 | $5K | Sell |
956
-11,194
| -92% | -$58.5K | ﹤0.01% | 1829 |
|
|
2019
Q4 | $106K | Sell |
12,150
-7,989
| -40% | -$69.7K | 0.01% | 776 |
|
|
2019
Q3 | $68K | Buy |
20,139
+15,105
| +300% | +$51K | ﹤0.01% | 916 |
|
|
2019
Q2 | $25K | Buy |
5,034
+3,594
| +250% | +$17.8K | ﹤0.01% | 1163 |
|
|
2019
Q1 | $9K | Sell |
1,440
-1,380
| -49% | -$8.63K | ﹤0.01% | 1282 |
|
|
2018
Q4 | $9K | Buy |
2,820
+786
| +39% | +$2.51K | ﹤0.01% | 1287 |
|
|
2018
Q3 | $13K | Buy |
2,034
+1,833
| +912% | +$11.7K | ﹤0.01% | 1117 |
|
|
2018
Q2 | $1.54K | Sell |
201
-62
| -24% | -$475 | ﹤0.01% | 1449 |
|
|
2018
Q1 | $6K | Buy |
+263
| New | +$6K | ﹤0.01% | 1195 |
|
|
2017
Q4 | – | Sell |
-490
| Closed | -$8K | – | 1843 |
|
|
2017
Q3 | $8K | Buy |
+490
| New | +$8K | ﹤0.01% | 1141 |
|